Serina Therapeutics, Inc. Cash Provided by (Used in) Operating Activities, Discontinued Operations
Serina Therapeutics, Inc. (SER) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$90.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2023-03-31
- Serina Therapeutics, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2021-12-31 was $0.00.
- Serina Therapeutics, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Serina Therapeutics, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2021-06-30 was $0.00.
- Serina Therapeutics, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2021-03-31 was -$90.00K, a 151.14% decline year-over-year.
- Serina Therapeutics, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2021 was -$90.00K, a 147.12% decline from fiscal 2020.
- Serina Therapeutics, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2020 was $191.00K.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | -$90.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | -$90.00K 10-Q · filed 2022-11-10 | -$91.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$90.00K 10-Q · filed 2022-08-12 | -$91.00K derived: sum of 3 quarters · filed 2022-08-12 | $17.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$90.00K 10-Q · filed 2022-05-13 | -$91.00K derived: sum of 2 quarters · filed 2022-05-13 | $17.00K derived: sum of 3 quarters · filed 2022-05-13 | -$75.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $107.00K derived: sum of 2 quarters · filed 2022-03-29 | $15.00K derived: sum of 3 quarters · filed 2022-03-29 | $191.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $16.00K derived: sum of 2 quarters · filed 2021-11-12 | $192.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $84.00K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $176.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |